Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Meihua International Medical Technologies Co Ltd (MHUA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/13/2025: MHUA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Analysis of Past Performance
Type Stock | Historic Profit -11.74% | Avg. Invested days 30 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/13/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 10.70M USD | Price to earnings Ratio 0.91 | 1Y Target Price - |
Price to earnings Ratio 0.91 | 1Y Target Price - | ||
Volume (30-day avg) 154682 | Beta 0.5 | 52 Weeks Range 0.25 - 1.47 | Updated Date 04/1/2025 |
52 Weeks Range 0.25 - 1.47 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.37 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 9.85% | Operating Margin (TTM) 12.99% |
Management Effectiveness
Return on Assets (TTM) 4.2% | Return on Equity (TTM) 6.42% |
Valuation
Trailing PE 0.91 | Forward PE - | Enterprise Value 3976962 | Price to Sales(TTM) 0.11 |
Enterprise Value 3976962 | Price to Sales(TTM) 0.11 | ||
Enterprise Value to Revenue 0.04 | Enterprise Value to EBITDA 0.32 | Shares Outstanding 31904500 | Shares Floating 13060989 |
Shares Outstanding 31904500 | Shares Floating 13060989 | ||
Percent Insiders 49.95 | Percent Institutions 0.8 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Meihua International Medical Technologies Co Ltd
Company Overview
History and Background
Meihua International Medical Technologies Co Ltd. was founded in 2012. Meihua is a medical device supplier focused on Class I, II, and III disposable medical devices used in surgeries, critical care, and other healthcare settings.
Core Business Areas
- Disposable Medical Devices: Manufacturing and distribution of various disposable medical devices, including wound care, infection control, and surgical products.
Leadership and Structure
The leadership team consists of CEO, board of directors. The organizational structure is typical for a manufacturing company with departments for R&D, production, sales, and marketing.
Top Products and Market Share
Key Offerings
- Surgical Drapes: Disposable surgical drapes for operating rooms. Competitors include Cardinal Health (CAH) and Owens & Minor (OMI). No specific market share data available.
- Surgical Gowns: Disposable surgical gowns. Competitors include Cardinal Health (CAH) and Owens & Minor (OMI). No specific market share data available.
Market Dynamics
Industry Overview
The medical device industry is growing due to aging populations, technological advancements, and increasing healthcare spending. The disposable medical device segment is driven by infection control and convenience.
Positioning
Meihua operates in a competitive market, focusing on providing cost-effective disposable medical devices. They are positioning as a low-cost manufacturer for global markets.
Total Addressable Market (TAM)
The global medical disposables market is substantial. TAM is projected to reach hundreds of billions USD. Meihua is a small player with limited market capitalization, positioned to grow as a low-cost alternative.
Upturn SWOT Analysis
Strengths
- Low-cost manufacturing capabilities
- Focus on disposable medical devices
- Established distribution network in certain markets
Weaknesses
- Limited brand recognition
- Dependence on a few key products
- Smaller scale compared to major competitors
- Potential quality control issues
Opportunities
- Expanding into new geographic markets
- Developing innovative disposable medical devices
- Acquiring smaller competitors
- Growing demand for infection control products
Threats
- Intense competition from larger players
- Stringent regulatory requirements
- Fluctuations in raw material costs
- Potential product recalls
Competitors and Market Share
Key Competitors
- CAH
- OMI
- MDT
- BDX
Competitive Landscape
Meihua faces stiff competition from much larger companies with greater resources and brand recognition. Its advantage is lower costs, but its small size and limited product line hinder its ability to compete broadly.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth depends on historical financial data available in SEC filings.
Future Projections: Future projections are based on analyst estimates and management guidance. These vary over time; please consult financial news sources.
Recent Initiatives: Information not available without constant updates of SEC filings.
Summary
Meihua International Medical Technologies is a small player in a large, competitive market. The company's low-cost manufacturing is a key advantage, but it needs to address its limited brand recognition and product diversification. Growth will depend on expanding into new markets and developing innovative products. It needs to be watchful of competition from larger, well-established companies.
Similar Companies
- CAH
- OMI
- MDT
- BDX
Sources and Disclaimers
Data Sources:
- Company SEC filings
- Financial news articles
- Industry reports
- Company Investor Relations Website
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data is estimated and may not be precise. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Meihua International Medical Technologies Co Ltd
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2022-02-16 | CEO & Director Mr. Wang Xin | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 617 | Website https://www.meihuamed.com |
Full time employees 617 | Website https://www.meihuamed.com | ||
Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People's Republic of China. The company offers class I, II, and III disposable medical devices. Its products include disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylene bottles for eye drops, and high-density polyethylene bottles for tablets; and disposable full anesthesia kits, medical brushes, woman's examination kits, urethral catheterization kits, gynecological examination kits, endotracheal intubation kits, medical masks, anal bags, and suction connecting tubes. It also provides disposable infusion pumps, anesthesia puncture kits, electronic pumps, etc. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.